UTHR icon

United Therapeutics

510 hedge funds and large institutions have $12.3B invested in United Therapeutics in 2022 Q4 according to their latest regulatory filings, with 89 funds opening new positions, 168 increasing their positions, 177 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

more call options, than puts

Call options by funds: $ | Put options by funds: $

11% more funds holding

Funds holding: 459510 (+51)

5% less repeat investments, than reductions

Existing positions increased: 168 | Existing positions reduced: 177

1.55% less ownership

Funds ownership: 99.67%98.12% (-1.5%)

Holders
510
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
23
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$50.3M
Puts
$43.5M
Net Calls
Net Calls Change

Top Buyers

1 +$337M
2 +$51M
3 +$50.9M
4
Morgan Stanley
Morgan Stanley
New York
+$36.9M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$35.2M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$9.45M
127
$9.18M
128
$9.17M
129
$8.55M
130
$8.52M
131
$8.45M
132
$8.17M
133
$8.14M
134
$8.08M
135
$8M
136
$7.98M
137
$7.97M
138
$7.97M
139
$7.93M
140
$7.83M
141
$7.56M
142
$7.53M
143
$7.5M
144
$7.48M
145
$7.36M
146
$7.28M
147
$7.28M
148
$7.14M
149
$7.04M
150
$6.98M